Physician profile
Gregory Allen Smith
NPI 1639101520
$4,230.79
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $1,768 · 2021: $816 · 2022: $722 · 2023: $531 · 2024: $23.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,064.53 | 2020-2022 | |
| Smith+Nephew, INC. | $249.51 | 2019-2023 | Stravix Pl, Grafix Pl, Oasis |
| Abbott Laboratories | $141.57 | 2019-2023 | Diamondback Peripheral |
| Tactile Systems Technology INC | $139.56 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Convatec INC. | $134.99 | 2023 | |
| Melinta Therapeutics, LLC | $89.36 | 2019 | |
| Rikco International, LLC | $88.00 | 2019 | |
| Organogenesis INC. | $73.70 | 2019-2023 | Puraply |
| Kerecis Limited | $73.25 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $63.95 | 2019-2022 | |
| Amgen INC. | $23.80 | 2024 | Krystexxa |
| Pfizer INC. | $19.46 | 2019 | |
| Horizon Therapeutics Plc | $18.23 | 2023 | Krystexxa |
| Merck Sharp & Dohme LLC | $15.23 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $12.71 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mckesson Patient Care Solutions INC. | $11.57 | 2019 | |
| Sebela Pharmaceuticals INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.